HPAPI expansion for Axplora

CDMO Axplora has announced plans to build a 4,500 m², three-storey R&D and laboratory hub for HPAPI manufacturing at scale at its Farmabios site in Gropello Cairoli, Italy. Farmabios already operates one of Europe’s largest HPAPI manufacturing workshops, with five independent lines and 105 m³ of capacity, supporting batch sizes from 0.5 to 300 kg.

The new facility, which should be complete in February 2027, will house R&D, QC and microbiology laboratories and integrated support areas, directly connected to existing manufacturing operations. “Co-locating development, analytics and large-scale HPAPI production within a single specialised site eliminates multi-site delays, improves scale-up efficiency and enhances overall programme economics,” the company stated.